According to a recent LinkedIn post from Brevel Ltd, the company recently visited a cosmetics customer to work on integrating its Purallis chlorella ingredient into that customer’s formulations on a live production line. The post highlights that this represents another step in bringing microalgae-based ingredients into personal care applications.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post emphasizes the functional properties attributed to chlorella in cosmetics, including antioxidants, vitamins, amino acids, and potential benefits related to hydration, elasticity, and cell regeneration. It also frames Purallis as a clean, plant-based active ingredient aimed at aligning with current consumer preferences in the beauty and personal care sector.
For investors, the activity described suggests early-stage commercial engagement and product integration efforts with cosmetics manufacturers, which could be a precursor to broader adoption if trials are successful. Demonstrated use on a real production line may indicate movement from lab-scale validation toward scalable applications, potentially supporting future revenue growth in the ingredient supply segment.
The focus on microalgae-derived actives for cosmetics may also position Brevel Ltd within a niche of sustainable, plant-based inputs that are gaining attention among global beauty brands. If the company can convert these formulation tests into long-term supply relationships, it could strengthen its competitive position in the high-value personal care ingredient market and diversify its customer base.

